PFIZER has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-17* | 3 Jun-18* | 3 Sep-18* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 5,711 | 5,123 | 5,197 | 1.5% | -9.0% |
Other income | Rs m | 237 | 305 | 371 | 21.4% | 56.3% |
Turnover | Rs m | 5,948 | 5,428 | 5,568 | 2.6% | -6.4% |
Expenses | Rs m | 4,039 | 3,822 | 3,900 | 2.0% | -3.4% |
Gross profit | Rs m | 1,672 | 1,301 | 1,298 | -0.3% | -22.4% |
Depreciation | Rs m | 160 | 183 | 177 | -3.0% | 10.7% |
Interest | Rs m | 2 | 2 | 2 | 29.4% | 37.5% |
Profit before tax | Rs m | 1,748 | 1,422 | 1,489 | 4.7% | -14.8% |
Tax | Rs m | 636 | 504 | 531 | 5.4% | -16.6% |
Profit after tax | Rs m | 1,112 | 918 | 958 | 4.3% | -13.8% |
Gross profit margin | % | 29.3 | 25.4 | 25.0 | ||
Effective tax rate | % | 36.4 | 35.4 | 35.7 | ||
Net profit margin | % | 18.7 | 16.9 | 17.2 |
To see how PFIZER has performed over the last eight quarters, please visit here.
Over the last one year, PFIZER share price has moved up from Rs 1,908.5 to Rs 2,783.3, registering a Gain of Rs 874.8 or around 45.8%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,206.5 (down 0.2%). Over the last one year it has moved up from 13,548.3 to 14,206.5, a gain of 658 points (up 4.9%).
Overall, the S&P BSE SENSEX is up 6.8% over the year.
At the current price of Rs 2,783.3, the price to earnings (P/E) ratio of PFIZER stands at 33.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.7 times.
| |
For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.
For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.
Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.
Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsA single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.
What we can learn from one of the greatest traders to have ever lived.
Should you invest in growth stocks or value stocks to make strong returns in this market?
Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.
The lowest hanging fruit for government to raise capital would be to sell off stakes in non-critical PSUs.
More
| |
Equitymaster requests your view! Post a comment on "PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!